NCT03887429View on ClinicalTrials.gov

Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal

PHASE2CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

March 4, 2019

Primary Completion Date

July 2, 2019

Study Completion Date

July 9, 2019

Conditions

Impulse Control Disorders

Interventions

DRUG

SXC-2023

SXC-2023 oral capsules

DRUG

Placebos

Matching Placebo oral capsules

Trial Locations (2)

68502

Celerion Inc., Lincoln

77030

Baylor College of Medicine, Houston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Celerion

INDUSTRY

collaborator

Baylor College of Medicine

OTHER

lead

Promentis Pharmaceuticals, Inc.

INDUSTRY